期刊文献+

p^(53)基因与Rb基因在卵巢癌组织中突变的初步分析 被引量:1

Preliminary analysis of p53 gene and Rb gene mutation in ovarian cancer tissue.
下载PDF
导出
摘要 为了解卵巢癌组织中抗癌基因p53与Rb基因的突变情况,我们把PCR单链构象多态(PCR-SSCP)银染技术及PCR-DNA直接测序方法应用于57例卵巢癌组织细胞的检测。结果发现p53基因可能的突变率为32%,Rb基因可能的突变率为21%,不同分化程度肿瘤的p53及Rb基因突变率未见明显区别。结论,PCR-SSCP银染技术是筛查基因突变简便、敏感、无核素污染的最佳方法。 Objective: To recognize the mutation status of p53 and Rb cancer suppresor genes. Methods: for the first time, 57 ovarian cancer samples were analysised by PCR for DNA amplification, and then SSCP, furthes PCR DNA sequence. Results:(1) The mutation ratio of p53 in ovarian cancer was 32%, (2) The mutation of Rb gene in ovarian cancer was 21%, (3)Neither p53 nor Rb gene mutation ratio was found significant difference in varions differential stages. Conclusions: PCR SSCP DNA sequence method is the best one in testing gene mutation for its simplicity, sensitivity and no radioisotope contamination. Direct PCR DNA sequence can test point mutation of single amino acid change.
出处 《中国优生与遗传杂志》 1998年第3期15-17,20,共4页 Chinese Journal of Birth Health & Heredity
关键词 卵巢癌 P53基因 RB基因 PCR-SSCP Ovarian cancer, p53 gene, Rb gene, PCR SSCP, Direct PCR DNA sequence.
  • 相关文献

同被引文献22

  • 1姚桂梅,康志海.p53肿瘤抑制基因与卵巢癌[J].国外医学(遗传学分册),1995,18(3):152-155. 被引量:4
  • 2姜彦多,王永信,关婷,王继红,王晓牧.抑癌基因P53突变产物表达与卵巢癌预后的关系[J].解放军医学杂志,1996,21(1):38-39. 被引量:1
  • 3李力,陈心秋,陈忠,黄薇,陈发龙,张洁清,唐步坚.卵巢肿瘤组织中的P-糖蛋白表达及其临床意义探讨[J].中国肿瘤临床,1997,24(1):43-45. 被引量:6
  • 4Umekita Y, Ohi Y, Sagara Y, et al. Overespression of CyclinD1 predicts for poor prognosis in estrogen receptor negative brest cancer patients[J]. Int J Cancer,2002,98(3) :415.
  • 5Yamamoto H,Ochiya T, Takeshita F, et al. Enhanced skin carcino- genesia in cyclinD1 - conditional transgenic mice:cyclinD1 alters keratiaocyte response to calcium - induced terminal differentiation[J]. Cancer Res,2002,62(6) : 1641.
  • 6Hrycyna CA, Ramachandra M, Ambudkar SV. Mechanism of action of human P - glycoprotein ATPase activity photochemical cleavage during a catalytic transition stage using orthovanadate reveals cross- talk between the two sides[J].J Biot Chem,1998.273(27) : 16631.
  • 7Masci AM, Scala S. Racioppi L, et al. Cell surface expression of major histocmopatibility class 1 antigens is modulated by P- glycoprotein transporter[J]. Hum Immunol, 1995,42 (3) : 245.
  • 8Nakayama K, Takebayashi Y, Nakayama S, et al. Prognostic value of overexpression of P^53 in human ovarian carcinoma patients receiving ciplain[J]. Cancer Lett, 2003,192 : 227.
  • 9Skirnisdottir I, Seidal T, Gerdin E, et al. The prognostic importance of P^53, bcl - 2, and bax in early stage epithelial ovarian carcinoma treated with adjuvant chemotherapy [J ]. Int J Gynecol Cancer,2002,12:265.
  • 10Ozalp S, Yalcin OT, Minsin TH. Expression of p^53 in epithelial ovarian cancer[ J ]. Int J Gynecol Obstet, 2000,71 (3) : 277.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部